Trials / Completed
CompletedNCT02961361
the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- The First Hospital of Qinhuangdao · Other Government
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Dexmedetomidine is an α-2 adrenoreceptor agonist and has been extensively used through intravenous infusion，in order to improved the quality of block in regional anesthesia. In this prospective, randomized study, the authors focus on the effect of dexmedetomidine mixed with ropivacaine in coracoid approach brachial plexus block.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ropivacaine | 40 ml 0.375% ropivacaine was injected after Locating brachial plexus. |
| DRUG | ropivacaine mixed with dexmedetomidine | 40 ml 0.375% ropivacaine mixed with dexmedetomidine was injected after Locating brachial plexus. |
Timeline
- Start date
- 2016-11-12
- Primary completion
- 2017-03-30
- Completion
- 2017-05-25
- First posted
- 2016-11-11
- Last updated
- 2023-02-15
Source: ClinicalTrials.gov record NCT02961361. Inclusion in this directory is not an endorsement.